Latest Acelot News & Updates

See the latest news and media coverage for Acelot. We track all announcements, press releases, and industry mentions in real time, all in one place.

Acelot

Biotechnology company developing small-molecule drugs for neurodegenerative diseases

acelot.com

Headquarters: South San Francisco, United States
Company type: Private company
Number of employees: 2–30
Industry: Pharmaceuticals

Last updated Today

Latest news about Acelot

In short: Acelot presented preclinical data for lead drug ACE-2223, appointed a new CMO, and announced plans for first-in-human trials next year.

Company announcements

August 19 Acelot

Acelot presents preclinical data for its ALS drug

The team will present findings at a dedicated booth, support community awards, and encourage patients to enroll in upcoming trials.

August 12 Acelot

Acelot appoints Mark Forman as CDO and CMO

He brings translational research expertise to guide the company's development strategy as it advances a pipeline targeting neurodegenerative diseases.

June 23 Acelot

Acelot presents preclinical data on ACE-2223 at ENCALS

Vidhu Mathur's poster shows ACE-2223 treats TDP-43 pathology and extends survival in mice.

1 October 2025 Acelot

Acelot presents ACE-2223 progress at NEALS

CEO Dr. Katie Planey speaks on October 8th at 2pm ET in Florida. Poster 151 follows on October 9th. FIH trials start next year.

Media coverage

August 12 BioSpace

Acelot Announces Appointment of Mark Forman, M.D., Ph.D., as Chief Development Officer and Chief Medical Officer

Seasoned neuroscientist with extensive translational experience advancing early-stage clinical assets joins Acelot to support the continued development of ACE-2223 targeting TDP-43 for the treatment ...

Never miss news about Acelot

Track Acelot and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Acelot competitors & trending companies

Browse news for competitors to Acelot and other trending companies.